A method for purification, identification and validation of DNMT1 mRNA binding proteins by Unterberger, Alexander et al.
Biol. Proced. Online 2008; 10(1): 47-57
doi:10.1251/bpo142
March 28, 2008
A method for purification, identification and validation of
DNMT1 mRNA binding proteins
Alexander Unterberger*, Jérôme Torrisani* and Moshe Szyf
#
*These authors contributed equally to this manuscript.
#Corresponding Author:  Moshe Szyf, Ph.D.,  Department of Pharmacology and Therapeutics, McGill University, 3655, Sir William-Osler Promenade,
Montreal, QC, H3G 1Y6. Phone:  (514) 398 7107; E-mail: moshe.szyf@mcgill.ca
Submitted: October 16, 2007; Revised: January 28, 2008; Accepted: January 31, 2008
Indexing terms:  DNA (cytosine-5-)-methyltransferase 1; DNA Methylation;  RNA-Binding Proteins
Abbreviations:  AUF1,  AU-rich element ARE:poly-(U)-binding/degradation factor; DNMT1, DNA methyltransferase 1
ABSTRACT
DNA methyltransferase 1 (DNMT1) is the enzyme responsible for the maintenance of DNA methylation patterns
during cell division. DNMT1 expression is tightly regulated within the cell cycle. Our previous study showed that the
binding of a protein with an apparent size of ~40 kDa on DNMT1 3’-UTR triggered the destabilization of DNMT1
mRNA transcript during Go/G1 phase. Using RNA affinity capture with the 3’-UTR of DNMT1 mRNA and matrix-
assisted laser desorption-time of flight tandem mass spectrometry (MALDI-TOF-MS-MS) analysis, we isolated and
identified AUF 1 (AU-rich element ARE:poly-(U)-binding/degradation factor) as the binding protein. We then
validated the role of this protein in the destabilization of DNMT1 mRNA. In this report, we detail the different
approaches used for the isolation, the identification of a RNA binding protein and the validation of its role.
INTRODUCTION
DNA methylation patterns are an essential component of
the epigenome, which regulates gene expression. DNA
Methyltransferase 1 (DNMT1) is the enzyme necessary for
maintenance   and   propagation   of   DNA   methylation
patterns through the process of DNA replication. Previous
studies have determined that levels of DNMT1 mRNA
vary at different phases of the cell cycle with observed
levels of DNMT1 at their highest in S phase, and lowest at
G0/G1  (1,2).   Furthermore,   it   has   been   observed   that
expression of DNMT1 gene does not change through the
cell cycle (3). Therefore it was proposed that a regulation
element controlled the levels of DNMT1 mRNA in cycling
cells. Detich et al. observed a ~40 kDa protein that bound
the 3’-Untranslated Region (3’-UTR), which was shown to
be essential for the cell cycle regulation of the mRNA, in a
cell cycle dependent manner (4).
We determined the identity of this ~40 kDa DNMT1 3’-
UTR binding element through RNA affinity purification
and protein sequencing by MALDI-TOF MS/MS, as AUF1
(5).   AUF1,   or   AU-rich   element   (ARE)/poly-(U)-
binding/degradation   factor,   or   heterogeneous   nuclear
ribonucleoprotein D (hnRNP D) (6,7), has been previously
shown to increase the destabilization of target mRNAs
(8,9), including  p16, p21, Cyclin D1 and c-fos (10-12).
Furthermore, we showed that AUF1 destabilizes DNMT1
mRNA in an exosomal dependent manner. Previous work
has   shown   that   AUF1   physically   interacts   with
components   of   the   exosome,   a   complex   of   3’-5’
exonucleases (13) and serves as a recruitment tool for the
mRNA to the exosome. Finally regulation of DNMT1
mRNA  by AUF1   occurred   in   a   cell  cycle  dependent
manner (5). Other members of the DNMT family, which
include DNMT3a and DNMT3b, have been shown to vary
in mRNA levels in a cell cycle dependent manner (2).
In this paper, we will discuss the methods used in our
study to identify AUF1, as well as the techniques used to
validate its regulation of DNMT1 mRNA.
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MATERIALS AND METHODS
Purification of DNMT1 3’-UTR binding proteins
Biological samples
Serum-starved pellets of HeLa cells were purchased from
Cilbiotech (Belgium). A total number of 3.10
9 cells were
used   for   the   purification   and   mass   spectrometry
identification. The cells were resuspended in 20 ml of
whole cell extraction buffer (20 mM Tris HCl; 0.4 M KCl;
20%   glycerol;   2   mM   DTT   and   Complete   Protease
Inhibitor
® (Roche Diagnostics)). The cells were incubated
overnight at -80
oC and centrifuged twice at 13 000 rpm for
15   minutes.   The   supernatant   was   collected   for
purification.
In vitro transcription of the substrate RNA
Substrate RNAs were transcribed from pSP64-poly-(A)
Control   (Promega)   and   pSK   3’-UTR   DNMT1-poly(A)
(DNMT1   3’-UTR)   plasmids   using   SP6   and   T3
polymerases,   respectively,   using  in   vitro  MEGAscript
transcription   kit   (Ambion).   DNMT1   3’-UTR   sequence
corresponds to the conserved region from the positions
5349 to 5405 of the DNMT1 mRNA (GenBank accession
number NM001379.1) annealed with a poly-(A) sequence.
RNA affinity chromatography
Five hundred micrograms of  in vitro-transcribed RNA
(DNMT1 3￿-UTR or Control) were hybridized with 500 mg
of   oligo-(dT)-cellulose   beads   (Sigma-Aldrich)   in
incubation buffer (10 mM HEPES, pH 8.0; 3 mM MgCl2; 40
mM KCl; 20% glycerol; 1 mM DTT and Complete protease
inhibitors
®)   (final   volume   5   ml).   Whole-cell   protein
extracts   (1   mg)   from   serum-starved   HeLa   cells   were
incubated overnight at 4°C with either control or DNMT1
3’-UTR  RNA  probes   annealed   to  oligo-(dT)  beads  in
incubation   buffer   supplemented   with   tRNA.   Protein-
RNA-bead complexes were pelleted (~1 ml), and unbound
proteins were eliminated by two washes (20 ml) in the
incubation buffer and five 20 ml-washes with washing
buffer (10 mM HEPES, pH 8.0; 3 mM MgCl2; 40 mM KCl;
20% glycerol; 1 mM DTT; 500 mM NaCl and Complete
protease inhibitors
®). Bound proteins were eluted by a
step-wise gradient (0.8 M to 4.3 M NaCl) (3 elutions of
1 ml each). The fractions from each NaCl concentration
were desalted and concentrated using Amicon Ultra-4
centrifugal   filters   (Millipore).   Five   microliters   of   the
concentrated fraction were loaded onto 15% acrylamide
gels and were verified for purification by silver staining
using the BioRad silver staining kit (BioRad). Gels were
stained   with   Coomassie   Blue   for   mass   spectrometry
analysis.   Coomassie   Blue   Staining   was   performed   by
fixing the gel (50% methanol, 10% glacial acetic acid),
staining for 20 minutes (0.1% Coomassie Brilliant Blue
R-250, 50% methanol, 10% glacial acetic acid). The gels
were destained with destaining solution (40% methanol,
10% glacial acetic acid), stored in 5% glacial acetic acid.
The gel was cut at the  ~40 kDa band and analyzed by
MALDI-TOF MS/MS
Protein identification by MALDI-TOF MS/MS analysis
MALDI-TOF   MS/MS:   DNMT1   3’-UTR-specific   binding
proteins were identified by comparing the DNMT1 3’-
UTR and the control lanes. Gel slices were excised and
digested with   porcine trypsin  on  a MassPrep  robotic
workstation (Micromass). Tryptic peptides were analyzed
on a QTrap 4000 ion trap mass spectrometer (Applied
Biosystems). The tryptic peptides were applied to Picco
Frit   columns   containing   BioBasic   C18  packing.   Eluted
peptides were electrosprayed as they exited the column,
and   doubly,   triply,   or   quadruply   charged   ions   were
selected for passage into a collision cell. MS-MS data were
analyzed by BioAnalyst 1.4 software (Applied Biosystems)
and   submitted   to   Mascot   (Matrix   Science)   for
identification by analysis against the NCBI non redundant
database.   MS-MS   analyses   were   performed   by   the
Genome Quebec Proteomic facility (Montreal, Quebec-
Canada).
Validation of AUF1 as a protein involvement in DNMT1
mRNA destabilization
RNA-protein UV cross-linking
HEK-293   cells   were   transiently   transfected   with
expressing   vectors  containing   cDNA  for   the  4  AUF1
isoforms   (p37,   p40,   p42   and   p45).   Reaction   mixture
containing either 20 µg of AUF1 transfectants or serum-
starved Hela cell extracts, [
32P]-labelled DNMT1 3’-UTR or
CT RNA probe (100 000 cpm/reaction) and 10 µg of tRNA
(as non specific inhibitor) were incubated for 1h on ice in
the following incubation buffer 10 mM Hepes, pH 7.6; 3
mM MgCl2; 40 mM KCl; 5% glycerol and 1 mM DTT. The
reactions were exposed to UV light for 10 minutes (254
nm) in UV-Stratalinker (Stratagene). Free unbound probe
was removed by  treating  the reaction  with  1.5  µl of
RNAse A (10 mg/ml) and 1 µl of RNAse T1 (1 Unit/ml)
(Roche   Diagnostics).   Protein-RNA   complexes   were
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resolved   on   a   10%   SDS-polyacrylamide   gel
electrophoresis.   Gels   were   dried   and   RNA-protein
complexes   were   visualized   by   exposition   to
PhosphorImager screen (Fujifilm imaging plate).
RNA immunoprecipitation
RNA immunoprecipitations were performed on HEK-293
or   HEK-293   cells   transfected   with   vectors   containing
FLAG   tagged-AUF1   isoforms.   FLAG-AUF1
immunoprecipitation reactions were performed using the
anti   FLAG-M2  agarose   beads  (Sigma-Aldrich).   Briefly,
whole cell extracts were incubated with M2 anti-FLAG
antibody-agarose   beads   overnight,   washed  four   times
with extraction buffer and total RNAs were extracted
using Trizol
®  reagent (Invitrogen). Immunoprecipitation
of RNA bound to endogenous AUF1 immunoprecipitation
was   performed   by   cross-linking   anti-AUF1   antibody
(Upstate Biotechnology) to protein G-agarose beads using
dimethylpimelimidate   (Sigma-Aldrich).   The
immunoprecipitated RNA were purified by Trizol
® RNA
extraction method. The beads were resuspended in 1 ml of
Trizol
®  and 200 µl of chloroform. The upper phase was
transferred   to   a   microfuge   containing   0.5   ml   of
isopropanol and RNA was precipitated by centrifugation
at maximum speed for 10 minutes. The RNA pellet was
resuspended in 50 µl of water  and was subjected to
DNAse I (Roche Diagnostics) treatment (10U in presence
of 5 mM MgCl2) overnight at 37°C) to remove any trace of
contaminating   DNA.  cDNAs   were   synthesized   by
treatment   of   RNAs   with   AMV   reverse-transcriptase
(Roche   Diagnostics)   following   the   manufacturer’s
recommendations. PCRs were performed as previously
described   (4)  using   the   following   primers:   DNMT1
forward 
(5’-ACCGCTTCTACTTCCTCGAGGCCTA-3’),   DNMT1
reverse   (5’-GTTGCAGTCCTCTGTGAACACTGTGG-3’),
b-actin forward (5'-GTTGCTATCC AGGCTGTGCTA-3'),
b-actin   reverse   (5'-GCGGATGTCCACGTCACACTT-3')
(11), p21 forward (5'-GCCCAGTGGACAGCGAGCAG-3’)
and p21 reverse (5'-GCCGGC GTTTGGAGTGGTAGA-3').
PCR   products   were   visualized   after   agarose   gel
electrophoresis and ethidium bromide staining.
In vitro degradation assays
RNA  decay   rates   were   assessed   using   the   following
protocol. Ten micrograms of whole extract of either AUF1
overexpressing cells or control cells and 250 000 cpm of in
vitro  synthesized DNMT1 3’-UTR or CT transcript were
incubated for 0 to 30 minutes at 37°C in 25 µl of reaction
buffer containing 10 mM Tris-HCl, pH 7.6; 100 mM KOAc;
2 mM Mg(OAc)2; 2 mM DTT; 0.1 mM spermine (Sigma-
Aldrich);   1   mM  ATP;   0.4   mM  GTP;   10   mM
phosphocreatine   (Sigma-Aldrich);   1   µg   creatine
phosphokinase   (Sigma-Aldrich)  and  1  unit/µl   Rnasin
®
(Roche Diagnostics). The reaction was stopped by adding
400 µl of stop reaction containing 10 mM Tris-HCl, pH 7.5;
350 mM NaCl; 10 mM EDTA; 2% SDS and 7 M urea. After
the addition of 20 µg of tRNA (Sigma-Aldrich) as a carrier,
the   RNA   was   purified   by   phenol:chloroform   (v/v)
extraction. The aqueous phase was transferred into a tube
containing   2   volumes  of  ethanol   and  was   mixed   by
vortexing. Following 20 minutes incubation in a dry ice
bath the RNA was precipitated by centrifugation at a
microfuge for 10 minutes at maximum speed. The pellet
was   washed   by   adding   ice-cold   70%   ethanol   and
cetrifugation. The radioactive pellets were air dried and
resuspended in water and denaturing RNA gel loading
buffer   (80%  formamide;   10   mM  EDTA;   1   mg/ml
bromophenol blue (Sigma-Aldrich) and 1 mg/ml  xylene
cyanol   (Sigma-Aldrich)).   The   samples   were   then
electrophoresed   on   denaturing   7  M  urea-5%  (1:29
bis:acrylamide)   polyacrylamide   gels.   The   radioactive
signals   were   visualized   by   autoradiography.  The
concentration of RNA at each time point was quantified
by densitometry of the autoradiogram and is presented in
the figure as the percentage of RNA remaining at each
time point relative to the concentration of RNA at time 0.
The half-life of the different RNAs was calculated from the
logarithmic decay plot.
Biological consequences of AUF1 depletion
[
3H]-Thymidine Incorporation
The rate of DNA synthesis was determined 24 h after
initiation   of   treatment   with   either   control,   AUF1   or
DNMT1 siRNA treated cells by measuring [
3H]-thymidine
incorporation into DNA following a 6-h pulse with 66
µCi/ml [
3H]-thymidine. [
3H]-thymidine incorporation was
assessed in triplicate of cells seeded at a density of 50 000
cells per well of a six well dish. The remaining three wells
of treated cells were counted to determine the overall
number of cells. Pulsed cells were washed five times with
phosphate  buffer   saline   (PBS)   and   incubated   in   10%
trichloroacetic acid at 4°C for 12 h. Cells were washed
twice with 5% trichloroacetic acid for 30 min. The cells
were lysed with 1% sodium dodecyl sulfate (SDS) in 1 N
NaOH, and the level of [
3H]-thymidine incorporation was
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measured in a liquid scintillation counter. The value of
thymidine   incorporation   was   normalized   by   the   cell
number for each treatment group. 
siRNA knock down of DNMT1 and AUF1
To deplete DNMT1 or AUF1 we used siRNA knock down
approach. Transfections of T24 cells were performed using
Lipofectin
®  transfection reagent (Invitrogen). Cells were
seeded at a density of 300 000 cells per 10 cm-dish. siRNA
oligonucleotides  were  purchased  from  Dharmacon.  24
hours after seeding, 100 nM of siRNA oligonucleotide was
incubated with 15 µl Lipofectin
®  and 4 ml Opti-MEM
serum-free media (Gibco-BRL) for 45 minutes at room
temperature. After incubation the incubation period, cell
medium was removed, cells were washed with PBS, and
siRNA:Lipofection
®:Opti-MEM mixture was added. The
cells were incubated for 4 hours after which the mixture
was   removed  and  replaced  with   McCoy 5A  medium
(Gibco-BRL). The cells were incubated in regular medium
for an additional 24 hours. The cells were harvested and
the siRNA knock down effectiveness was validated by
western blot analysis using antibodies for DNMT1 (NEB
#M0231S,  at a  dilution  of 1:1000) and AUF1 (Abcam
#ab50692, at a dilution of 1:1000). 
Assay of DNA Methyltransferase activity
The   rate   of   DNA   methyltransferase   activity   was
determined   in   human   fibroblasts   cells   (Coriell   Cell
Repository   #GM01887)   48   hours   after   treatment  with
either control or AUF1 siRNA. Transfections of fibroblasts
were   performed   using   Lipofectin
®  as   previously
described. Proteins were extracted from these cells by
freeze-thawing in lysis buffer (10 mM Tris-HCl, pH 7.6: 5
mM MgCl2; 0.3 M NaCl; 0.05% Tween
® and 10% Glycerol).
The lysed cells were pelleted at 13 000 rpm at 4°C and the
concentration   of   protein   in   the   supernatants   was
measured   using   the   BioRad   protein   assay   reagent
(Biorad).   Ten   micrograms   of   protein   extract   were
incubated with a poly-dIdC template, [
3H]-S-Adenosyl
Methionine (Sigma-Aldrich) in incubation buffer (40 mM
Tris-HCl, pH 7.6; 50% glycerol; 20 mM EDTA; 0.4 mM
PMSF and 60 mM b-Mercaptoethanol) for 3 hours at 37°C.
The reactions were stopped by incubation at 65°C for 10
min, 750 µl of 10% trichloroacetic acid (TCA) were added
to   the   reactions,   and   the   samples   were   incubated
overnight at 4°C. The reactions were filtered on GF/C
filters, washed twice with (TCA) and dried. Filters were
placed   in   scintillation   mixture   and   activity   was
determined   by   scintillation   counting.   Reactions   were
performed in triplicate.
Nearest Neighbour Analysis
Levels of 5-methylcytosine in DNA extracted from cells
transfected  with   either   control  or  AUF1   siRNA  were
measured   by   nearest-neighbour  analysis   as   described
previously (14). Two micrograms of genomic DNA were
incubated with MboI restriction enzyme (MBI-Fermentas)
at 37°C overnight. The reaction was heat-inactivated at
65°C for 20 minutes and the DNA was recovered by
ethanol precipitation. The MboI digested DNA was end-
labeled with 10 µCi [ - ￿
32P]-dGTP (Amersham),  0.5 µl
Klenow enzyme (Roche Diagnostics) and 1.5 µl of 10X
Labeling   buffer   (Roche   Diagnostics)   at   15°C  for   15
minutes. The reaction was stopped by addition of 2 µl of
0.2 M EDTA. Labeled DNA was purified by a Sephadex
G50 spin column (Roche Diagnostics). 8 µl of DNA were
digested   with   1   µl   of   Micrococcal   Nuclease   (Roche
Diagnostics), 1 µl of Spleen Phosphodiesterase (Roche
Diagnostics) and 1 µl of Micrococcal Nuclease buffer (250
mM   Tris-HCl,   pH   7.4   and   10   mM  CaCl2)   at   37  oC
overnight. Digested DNA was separated by Thin-Layer
Chromatography (TLC) on Polygram CEL 400 TLC sheets
(Macherey-Nagel) in two dimensions, the first dimension
solution   consists   of  66   volumes   isobutyric   acid:   18
volumes water: 3 volumes 30% ammonia solution, and the
second   dimension   solution   consists   of   80   volumes
saturated ammonium sulphate: 18 volumes 1 M acetic
acid:   2   volumes   isopropanol.   The   intensity   of   5-
methylcytosine  and cytosine mononucleotide spots was
measured using a PhosphorImager screen and the Image
Quant image analysis program (GE Healthcare). Levels of
unmethylated   cytosine   content   are   expressed   as   a
percentage of [cytosine]/[cytosine + methylcytosine].
RESULTS AND DISCUSSION
Isolation and identification of AUF1 as a 3’-UTR DNMT1
mRNA-binding protein by RNA affinity chromatography
and mass spectrometry
To  identify  the  ~40kDa  protein   which  binds  DNMT1
mRNA 3’-UTR specifically in Go/G1 phase of the cell cycle,
we employed a RNA affinity chromatography approach.
This technique use a specific RNA probe corresponding to
the DNMT1 3’-UTR sequence to capture the candidate
protein.   Like   other   chromatography   methods,   RNA
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affinity   chromatography   requires   a   large   amount   of
starting biological material to isolate sufficient amounts of
a  single  protein.  Using sufficient amounts of  starting
material is essential for the success of the purification
protocol. We started with one milligram of total protein
extracted from Hela cells arrested in Go/G1  of the cell
cycle.   We   first   verified   the   presence   of   the   ~40kDa
interacting protein in our extract by RNA-protein UV
cross-linking   (Fig.   1A).   The   protein-RNA  cross-linked
extracts were incubated with [
32P]-labelled RNA probes
corresponding to the DNMT1 3’-UTR or to a random
sequence (CT). 
The poly-(A) tailed-RNA probes were first annealed with
oligo-(dT)-cellulose  beads. The beads  were  extensively
washed after hybridization to remove non-annealed RNA
by resuspending the beads in incubation buffer followed
by centrifugation. The washed RNA bait-cellulose beads
(~1 ml) were incubated with one milligram of protein
extract overnight at 4°C  in   an  incubation  buffer  (see
Material and Methods) supplemented with 5 µg tRNA to
reduce non-specific binding. Beads were washed with the
incubation buffer two times followed by five washes with
incubation buffer, containing 500 mM NaCl, to remove
non-specific interactions. Washes are essential for high-
quality purification and must be performed in a large
volume (20 ml per ~1 ml-bead pellet) for at least 15
minutes per wash. Proteins bound to the RNA bait were
then eluted by step-wise salt gradient (0.8 M to 4.3 M
NaCl   0.5   ml   fractions).   RNA-protein   interactions   are
usually strong and required high salt concentrations to be
disrupted. Due to their large volume the elutions were
diluted and were therefore concentrated using  Amicon
Ultra-4 centrifugal filters (Millipore) and visualized by
SDS-polyacrylamide   electrophoresis   followed   by
Coomassie blue staining. 
A  ~40kDa protein  in the 3.2 M fraction,  was found to
interact specifically with DNMT1 3’-UTR RNA and not
with  the Control  RNA bait.  The band containing the
protein of interest was excised and analyzed by MALDI-
TOF-MS-MS. Since we were interested in the identification
of   a   ~40kDa   interacting   protein   responsible   for   the
destabilization of DNMT1 mRNA, we decided to excise
the band containing the ~40kDa protein. This technique
could have been applied to analyse all the bands in order
to identify all the RNA binding proteins interacting with
DNMT1 3’-UTR. Eight sequenced peptides corresponding
to the AUF1/hnRNP D protein which were common to all
of the four isoforms were identified in the MS/MS analysis
(Fig. 1B and C).
Other   methods   to   isolate   and   identify   RNA  binding
proteins have been developed. Many of them involve
affinity chromatography using an  in vitro  transcribed-
RNA bait. They differ in strategy by coupling the RNA
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Fig. 1: Isolation and identification of AUF1 as a 3’-UTR DNMT1
mRNA-binding   protein   by   RNA   affinity   chromatography   and
mass   spectrometry.   (A)  Cytoplasmic extract of serum-starved HeLa
cells were incubated and UV cross-linked with a radioactive DNMT1 3’-UTR
or Control RNA probe. The position of a ~40kDa interacting protein is
indicated by the arrow.  (B)  MS-MS spectrum of an identified peptide
corresponding to the AUF1/hnRNP D sequence. (C) Peptide sequences of
AUF1/hnRNP D isoforms. Peptide sequences identified by MALDI-TOF-MS-
MS are shown in boldface italic type. 52
bait to agarose or sepharose beads. For example, several
biotin-dUTP can be incorporated in the RNA by in vitro
transcription or chemically added to an extremity (15).
The bait is then coupled to the streptavidine-beads by one
or several nucleotides. In our method, the annealing of the
oligo-(dT)-beads with the poly-A tail of the RNA bait gave
a  better   flexibility  to  the  RNA  bait which  helped  in
obtaining   a   better   capacity  of   interaction   with   RNA
binding proteins. Recently developed, a technique makes
use of a short, 45-nt RNA StreptoTag aptamer capable of
binding   the   antibiotic   streptomycin   (16).   The   RNA
aptamer is linked in cis to the RNA sequence of interest in
order to form a single hybrid RNA molecule which is in
turn immobilised to a streptomycin-coupled sepharose
column. This technique is efficient for high- and low-
affinity RNA binding proteins. However, the coupling of a
45-nt aptamer to our RNA bait could have generated an
increase in non-specific interactions, due to similarities in
size (54-nt)
Validation of AUF1 as a protein involvement in DNMT1
mRNA destabilization
RNA-protein UV cross-linking
After we identified the ~40kDa protein interacting with
DNMT1 3’-UTR as AUF1, we aimed to confirm that AUF1
interacts specifically with the 3’UTR of DNMT1 using
several approaches. First, we verified the interaction of
AUF1 with the DNMT1 3’-UTR by RNA-protein cross-
linking (Fig. 2A). Whole cell extracts of HEK-293 AUF1
transfectants   were   incubated   with   [
32P]-labelled   RNA
probe corresponding to the DNMT1 3’-UTR conserved
sequence or a control sequence. Successful visualization of
the RNA-protein interaction is dependent on the quantity
of AUF1 protein in the cell extracts. For this reason we
chose   HEK-293   cells   which   can   be   transfected   by
expression vectors at a high efficiency. This assay revealed
that all four AUF1 isoforms can interact with DNMT1 3’-
UTR conserved sequence. 
RNA immunoprecipitation
RNA   immunoprecipitation   technique   detects   the
interaction of endogenous mRNA with the RNA binding
protein in the cell. This technique is tightly dependent on
the efficiency and the specificity of the interaction of the
antibody   to   its   target   protein.   We   determined   the
specificity and efficiency of AUF1 and FLAG antibodies
using Western blots and immunoprecipitation followed by
Western blot with the antibody. This technique allowed us
to detect the interaction of AUF1 with the endogenous
DNMT1 mRNA in HEK-293 cells as well as p21 mRNA,
which is a known AUF1 target (10) (Fig. 2B). The presence
of the 3’UTR of DNMT1 in the AUF1 immunoprecipitate
was determined by PCR with the relevant primers. We
used b-actin mRNA as an AUF1 non-interacting mRNA
negative control. The disadvantage of this technique is
that it is qualitative and non-quantitative. We utilized the
same technique with AUF1-tagged overexpressing cells to
determine that the four AUF1 isoforms can interact with
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Fig.   2:    Validation   of   AUF1   as   a   protein   involved   in   DNMT1
mRNA   destabilization.   (A)  RNA-protein   UV   cross-linking   assay.
Cytoplasmic extracts  of HEK-293  cells  transfected  with cDNAs  of the
different AUF1 isoforms or a control vector (CT) were incubated with [
32P]-
labelled   3’-UTR   DNMT1   (3’-UTR)   and   UV   cross-linked.   RNA-protein
complexes were resolved by SDS-polyacrylamide gel electrophoresis and
visualized by exposition to PhosphorImager screen. (B) AUF1 protein was
immunoprecipitated from HEK-293 extracts using anti-AUF1 antibody (left
panel). Immunoprecipitation (IP) using rabbit immunoglobulin G (IgG) was
performed as negative control. Immunoprecipitated RNAs, as well as RNA
present in an aliquot of the initial extracts (Input), were extracted and
subjected to reverse transcription.. Detection of DNMT1 and p21 mRNAs
was performed by PCR.  ￿-actin amplification was used as a negative
control. HEK-293 cells were transfected with AUF1 cDNAs or a control
vector (CT). Flag antibody-precipitated RNAs were extracted form the bead
pellets   (right   panel).   DNMT1   mRNAs   were   detected   by   RT-PCR   and
quantified.  ￿-actin amplification was used as a negative control.  (C)  In
vitro  degradation assay. Cytoplasmic extracts from transfected HEK-293
cells (CT or AUF1 cDNAs) were incubated with radiolabeled DNMT1 3’UTR
RNA transcript or control RNA probe for various lengths of time and
electrophoresed.   The   signals   were   detected   by   autoradiography   and
quantified by densitometry. The half-lives were obtained by determining the
time point at which 50% of the RNA had been degraded. 53
DNMT1 mRNA (Fig. 2B). This technique could easily be
quantified using an antibody against endogenous AUF1
and real time quantitative PCR amplification. 
In vitro degradation assay
The   previous   approaches   are   dedicated   to   the
determination   of   RNA-protein   interactions.  In   vitro
degradation assay allowed us to examine the role of a
protein   in   RNA   destabilization.   To   validate   the
involvement of AUF1 isoforms in the destabilization of
DNMT1 mRNA, we examined whether AUF1 altered the
stability of DNMT1 mRNA.  Using  this  approach,  we
showed   that   extracts   obtained   from   HEK-293   cells
ectopically   expressing   the   AUF1   isoforms   degraded
DNMT1 3’-UTR RNA at an accelerated rate (half-life t½:
10.5, 8.9, 12.0 and 9.0 min) relative to control vector-
transfected cell extracts that contained markedly lower
levels of endogenous AUF1 (t½: 27.3 min) (Fig. 2C). 
This   technique   contains   technical   difficulties   that   we
should mention. Indeed, for short kinetic studies (30 sec to
1 minute) of highly unstable mRNAs, the main difficulty
is to stop the reactions at the precise time point especially
when multiple samples are processed simultaneously. We
would advise the preparation of tubes containing stop
reaction buffer in advance. A major technical barrier is
proper homogenization of the emulsion during the phenol
chloroform   purification.   Inattentive   manipulation   can
generate inconclusive data. The presence of urea in the
polyacrylamide   gel   wells   sometimes   can   affect   the
migration, we advise a rapid rinse of the wells just before
loading.
Several techniques to validate the interaction of a protein
to   a   RNA   sequence   have   been   developed.   RNA
electrophoretic  mobility shift  assay (RNA-EMSA)  is  a
common   technique   used   to   characterize   protein:RNA
interactions (17). However,  the RNA:protein UV cross
linking   assay   that   we   use   here   provides   several
advantages. Because  the radioactive probe that is not
bound or not protected by the UV cross linked protein is
degraded by a RNAse A and T1 treatment. Only the
protein(s)   bound   to   the   probe   is   (are)   radioactively
labelled.   The   electrophoretic   migration   in   denaturing
conditions permits an estimation of the apparent size of
the   interacting   protein(s).   Furthermore,   the   RNA
probe:protein  complexes can be  electrotransfered onto
nitrocellulose membrane to perform Western blot analysis
in order to validate the identity of the protein present in
the complex. 
RNA immunoprecipitation is most appropriate technique
to validate an interaction mRNA:protein in vivo. However,
this technique requires antibodies with a high affinity and
specificity for the proteins. 
In vitro  degradation assay is an accurate technique to
measure the effects of a RNA interacting protein on the
stability of specific mRNA (18). However, this technique
requires the manipulation of radioactive probes and does
not reflect a situation in a cellular context. Cell treatment
by   Actinomycin   D   (transcription   blocker)   can   be   an
alternative to measure mRNA stability  in vivo  (5). After
Actinomycin D treatment, the content of different mRNAs
can be estimated by quantitative Real Time-PCR using
specific   primers.   For   example,   their   half  lives   in   the
presence of a RNA binding protein transiently expressed
in the cells can be calculated.
Biological consequences of an AUF1 depletion
[
3H]-Thymidine incorporation
To determine the biological significance of the regulation
of   DNMT1   mRNA   by   AUF1   we   assayed   relevant
biological endpoints related to the known cellular roles of
DNMT1. We examined the effect of AUF1 depletion on
DNA replication, as it has been previously shown that
depletion of DNMT1 inhibits DNA replication (19). We
performed   a   series   of   siRNA  AUF1   depletions   and
examined   the   effect   of  AUF1   knock   down   on   DNA
replication and then tested whether DNMT1 is involved in
the effect by concurrently depleting AUF1 and DNMT1.
We used T24 human bladder carcinoma cells since we
have previously used them to study the effects of DNMT1
depletion   on   DNA   replication   (5).   Our   siRNA   was
designed  to  target  all   four   isoforms  of AUF1,  which
effectively   eliminated   any   potential   redundancy   from
remaining AUF1 isoform. However, this strategy could
not allow us to isolate which AUF1 isoform was essential
in   DNMT1   mRNA  regulation.   Utilizing   the   fact  that
incorporation of [
3H]-thymidine into DNA serves as an
accurate   indicator   of   the  rate   of  DNA  synthesis,   we
observed that upon depletion of AUF1, the subsequent
increase in DNMT1 was associated with an increase in
DNA synthesis, further supporting the concept that an
increase in DNMT1 can affect DNA synthesis (19). To
validate   these   claims,   the   elimination   of   DNMT1   by
DNMT1 antisense in AUF1 siRNA treated cells returned
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the rate of DNA synthesis back to control levels (Fig. 3A).
The major drawback of this technique is that it utilizes
[
3H]-labelled   thymidine   and   a   dedicated   radioactive
facility would be required to perform any experiments.
We would recommend that during the lysis step described
in the methods the reaction mixture should be incubated
at 37°C as the SDS/NaOH solution precipitates at room
temperature. 
Assay of DNA methyltransferase activity
An essential criteria to demonstrate regulation of DNMT1
by AUF1 is to show that modulation of AUF1 would affect
the biochemical activity of the DNMT1 enzyme. DNA
methyltransferase   activity   assays   were   performed   on
nuclear extracts prepared from cells treated with either
control or AUF1 siRNA. We observed that the elevation in
DNMT1 levels induced by AUF1 siRNA depletion was
accompanied by an increase in methyltransferase activity
as expected (Fig. 3B). 
The DNA methyltransferase assay requires radioactive
labelled   SAM   and   therefore   necessitates   a   dedicated
radioactive facility. When performing this assay a range of
protein concentrations need to be taken to verify that we
are working at the linear range of the assay. In addition, a
time course has to be established to verify that the assay is
measuring the initial rate. We used the concentration of 10
µg in our experiments; however we performed a range of
concentrations ranging from 5 to 20 µg to determine a
linear   dose   response   at   this   range   of   concentrations.
Additionally, two background negative controls are used
per assay. First, [
3H]-S-Adenosyl Methionine (SAM) alone
with the reaction mixture but in the absence of protein
and the second control is protein extract with [
3H]-SAM in
absence of the DNA substrate poly-dIdC. The first control
serves   as   a   background   value   to   subtract   residual
unincorporated   SAM   from   all   readings.   The   second
control   serves   to   subtract   the   substrate-   independent
methylation activity in the nuclear extract. The values of
the first and second controls are subtracted from the
readings for the complete reaction mixtures. 
Nearest neighbour analysis
Following the determination of overall methyltransferase
biochemical activity as a function of modulation of AUF1,
we determined its effect on genomic DNA methylation
(Fig. 3C). We utilized the nearest neighbour method to
determine that AUF1 siRNA lead to a significant increase
in   CpG   methylation.   This   method   quantifies   all   the
neighbours of the last C in the sequence GATC in the
genome; CpC, CpA. CpT, CpG and 5methylCpG. Thus, it
gives   a   good   representation   of   the   global   state   of
methylation. As stated previously, this technique requires
a dedicated radioactivity facility suitable for working with
[
32P]-isotopes. Furthermore this technique would require a
chemical fumehood as the isobutyric acid used in the
chromatography medium is quite volatile. It will require
two chromatography glass tanks (Fisher Scientific) for
each of the dimensions to increase the amount of runs that
can be performed in a day. The technique involves certain
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Fig . 3: Biological consequences of AUF1 depletion. (A) T24 cells
were   transfected   with   CT   siRNA   (siCT),   AUF1   siRNA   (siAUF1),   or   a
combination   of   AUF1   siRNA   and   DNMT1   antisense   (DNMT1   AS)
oligonucleotide.   [
3H]-thymidine   uptake   was   measured   as   described   in
Materials and Methods. The results are averages plus standard deviations
from three independent experiments. Values that are statistically different
(*) as tested by a Student’s t test at a p<0.05 are indicated by the brackets.
 (B) Assay of DNA methyltransferase assay. DNA methyltransferase activity
in AUF1 siRNA (siAUF1)- or CT siRNA (siCT)-transfected human fibroblasts
was   measured   as   described   in   Materials   and   Methods.   The   graph
represents the averages plus the standard deviations from three different
experiments. An asterisk indicates statistical significance as tested by
Student t test at a p<0.05. (C) The level of CpG methylation in AUF1 siRNA
(siAUF1)- or CT siRNA (siCT)-transfected human fibroblasts was measured
by nearest-neighbour analysis. The graph represents the averages plus the
standard deviations from three different experiments. An asterisk indicates
statistical significance as tested by Student t test at a p<0.05. 55
challenges. First, the DNA should be treated with RNAse
to eliminate contaminating RNA. To preserve the integrity
of the DNA, the samples should not have been subjected
to any mechanical shear or restriction enzymes. When the
DNA  is   precipitated   after  MboI  treatment   great   care
should be taken to not disturb the DNA pellet as it is
barely visible. Preparation of the Sephadex G-50 spin
columns requires sterilized 8% Sephadex G-50 in Tris-HCl
EDTA   as   to   prevent   DNA   contamination   from   any
bacterial cultures. Bacteria are not methylated at the CG
dinucleotides but contain a significantly higher frequency
of CG dinucleotides than human DNA and can therefore
seriously confound the results. 
The   thin-layer   chromatographic   (TLC)   separation   of
nucleotides requires two TLC development tanks. The
first dimensional tank solution should be prepared the
day before the chromatography is performed to allow the
isobutyric acid to equilibrate with the ammonia solution.
The recommended size of the nylon-backed cellulose TLC
plates   is   10   cm   x   10cm   which   allows   for   separate
resolution of the cytosine and 5 methyl-Cytosine spots.
Distribution of the labelled nucleotides can be seen in
Fig 4. 
Summary
The methods described here can be utilized to identify
and   characterize  proteins   that  can  bind  and  regulate
mRNA  for   genes  expressing  DNA  methyltransferases.
Using   RNA   affinity   chromatography   and   mass
spectrometry   the   binding   protein   was   identified.
Interaction of the protein, AUF1, with DNMT1 mRNA was
further validated through RNA immunoprecipitations and
UV-cross linking with RNA substrate. The biological role
of the identified protein was seen through modulation of
its   levels   by   siRNA   knockdown   and   assays   were
performed  on  the intended  substrate,   including DNA
methyltransferase assays and nearest neighbour analysis
for global DNA methylation content. Other tests included
thymidine incorporation to determine the role of AUF1 on
DNA replication.
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PROTOCOLS
RNA affinity chromatography
1. Day 1. Lyse the cells in lysis buffer (see Materials and Methods) overnight at -80°C.
2. In vitro transcribed and purify the RNA bait using MEGAScript kit (Ambion). 
3. Anneal 500 µg of poly-(A) tailed-RNAs bait with 500 mg of oligo-d(T) cellulose beads and wash the unbound RNA
probes in excess. 
4. Incubate the RNA bait-cellulose beads matrix with 1 milligram of protein extracts overnight at 4°C in the incubation
buffer (see Materials and Methods).
5. Day 2. Wash twice with 20 ml of incubation buffer and 5 times with 20 ml of washing buffer (see Materials and
Methods).
6. Elute the RNA interacting proteins with step-wise salt gradient buffers (see Materials and Methods).
7. Concentrate and analyse the fractions on SDS polyacrylamide gel electrophoresis and Coomassie staining.
8. Identify the protein(s) by MALDI-TOF-MS-MS analysis.
RNA-protein UV cross-linking
1. Mix 20 µg of cell extracts with [
32P]-labelled RNA probe (100 000 cpm/reaction), 10 µg of tRNA in incubation buffer.
2. Incubate for 1h on ice.
3. Expose to UV light (254 nm).
4. Remove free unbound probe by RNAse A and T1 treatment. 
5. Resolve RNA-protein complexes by 10% SDS-polyacrylamide electrophoresis.
6. Visualize after exposure to a PhosphoImager screen.
RNA immunoprecipitation assay
1. Lyse the cell in the appropriate lysis buffer. 
2. Incubate cell extracts with anti Flag or anti AUF1 antibody coupled to agarose beads overnight at 4°C.
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3. Wash the pellets four times with a large volume of lysis buffer.
4. Extract RNA from the pellets using Trizol
® reagent.
5. Perform a reverse transcription on the extracted RNAs.
6. Detect the putative target RNA by PCR amplification.
7. Visualize the PCR products by agarose gel electrophoresis followed by ethidium bromide.
In vitro degradation assay
1. Lyse the cells in the appropriate lysis buffer.
2. Incubate 10 µg of whole extracts with [
32P]-labelled RNA probe (250 000 cpm) in an incubation buffer (see Materials
and Methods) for 0 to 30 minutes at 37°C.
3. Stop the reaction at different time by adding 400 µl of stop solution (see Materials and Methods).
4. After addition of tRNA as carrier, phenol:chloroform extraction and ethanol precipitation, radioactive pellets were
resuspended in 10 µl of water.
5. After   denaturation   in  RNA  gel   loading   buffer,   the  radioactive   mixtures   are  resolved  on   urea-denaturing
polyacrylamide gel electrophoresis.
6. Gels are dried and exposed to autoradiographic film.
7. The concentration of RNA at each time point was quantified by densitometry of the autoradiogram.
[
3H]-Thymidine incorporation assay
1. Add 1µCi/mL media of [
3H]-thymidine to cells. Incubate for 5-6h.
2. Wash cells 4-5 times with 2 ml of PBS.
3. Incubate cells in 2 ml of 10% TCA overnight at 4°C.
4. Wash cells twice with 2 ml of 5% TCA for 30 minutes each wash.
5. Lyse cells with 500 µl of 1% SDS /1N NaOH solution for 10 minutes at 37°C. Save lysate and repeat.
6. Place lysate in liquid scintillation counter tubes with 5ml of scintillation cocktail and read.
Assay of DNA methyltransferase activity
1. Incubate 10 µg of protein extract with 3.7 µM [
3H]-S-adenosyl methionine in incubation buffer (40 mM Tris HCl, pH
7.6; 50% glycerol; 20 mM EDTA; 0.4 mM PMSF and 60 mM b-mercaptoethanol) and 0.1 µg poly-dIdC at 37°C for 3
hours.
2. Heat inactivate solutions at 65°C for 10min.
3. Add 750 µl of 10% TCA solution and incubate at 4°C overnight.
4. Solutions are filtered on glass fiber filters and washed twice with 10% TCA.
5. Filters are dried, placed in 5 ml scintillation cocktail and counted.
Nearest neighbour analysis
1. Digest 2 µg of genomic DNA with 10 units of MboI overnight at 37°C.
2. Heat inactivate MboI at 70°C for 20 min.
3. Purify DNA by ethanol precipitation. Resuspend pellet in 10 µl of water
4. Label digested DNA with 10 µCi [￿-
32P]dGTP, 1.5µl of 10X labelling buffer (see Materials and Methods) and 0.5 µl of
Klenow enzyme at 15°C for 15 min.
5. Stop reaction with 2 µl of 0.2 M EDTA.
6. Purify DNA through a Sephadex G-50 spin column.
7. Digest 8 µl of flow-through with 1 µl of micrococcal nuclease, 1 µl of spleen phosphodiesterase and 1 µl of
micrococcal nuclease buffer (see Materials and Methods) overnight at 37°C.
8. Spot digestion solution at point of origin of TLC plate.
9. Run in 1
st dimension until the end of the plate. Dry plate under heat lamp.
10. Run in 2
nd dimension. Dry under heat lamp.
11. Visualize after exposure to a PhosphoImager screen.
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